Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Membership of the scientific board and Delphi respondents

From: Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts

Participating experts

Number

Specialty, n (%)

Hospital-based, n (%)1

University-based, n (%)1

Geographical origin, n (%)

Scientific board

10

Rheumatology, 9 (90)

Pediatrics, 1 (10)

6 (60)

8 (80)

Northern Italy, 7 (70)

Central Italy, 2 (20)

Southern Italy, 1 (10)

Bibliographic board

4

Rheumatology (100)

2 (50)

3 (75)

Northern Italy, 3 (75)

Central Italy, 1 (25)

Delphi respondents

49

Rheumatology (100)

22 (45)

43 (88)

Northern Italy, 20 (41)

Central Italy, 18 (37)

Southern Italy, 11 (22)

  1. 1Percentages do not add to 100 because some experts are both hospital- and university-based
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us